Passoja K, Rautavuoma K, Ala-Kokko L, Kosonen T, Kivirikko K I
Collagen Research Unit, Biocenter and Department of Medical Biochemistry, University of Oulu, FIN-90220 Oulu, Finland.
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10482-6. doi: 10.1073/pnas.95.18.10482.
Lysyl hydroxylase (EC 1.14.11.4), a homodimer, catalyzes the formation of hydroxylysine in collagens. Recently, an isoenzyme termed lysyl hydroxylase 2 has been cloned from human sources [M. Valtavaara, H. Papponen, A.-M. Pirttilä, K. Hiltunen, H. Helander and R. Myllylä (1997) J. Biol. Chem. 272, 6831-6834]. We report here on the cloning of a third human lysyl hydroxylase isoenzyme, termed lysyl hydroxylase 3. The cDNA clones encode a 738 amino acid polypeptide, including a signal peptide of 24 residues. The overall amino acid sequence identity between the processed human lysyl hydroxylase 3 and 1 polypeptides is 59%, and that between the processed lysyl hydroxylase 3 and 2 polypeptides is 57%, whereas the identity to the processed Caenorhabditis elegans polypeptide is only 45%. All four recently identified critical residues at the catalytic site, two histidines, one aspartate, and one arginine, are conserved in all these polypeptides. The mRNA for lysyl hydroxylase 3 was found to be expressed in a variety of tissues, but distinct differences appear to exist in the expression patterns of the three isoenzyme mRNAs. Recombinant lysyl hydroxylase 3 expressed in insect cells by means of a baculovirus vector was found to be more soluble than lysyl hydroxylase 1 expressed in the same cell type. No differences in catalytic properties were found between the recombinant lysyl hydroxylase 3 and 1 isoenzymes. Deficiency in lysyl hydroxylase 1 activity is known to cause the type VI variant of the Ehlers-Danlos syndrome, and it is therefore possible that deficiency in lysyl hydroxylase 3 activity may lead to some other variant of this syndrome or to some other heritable connective tissue disorder.
赖氨酰羟化酶(EC 1.14.11.4)是一种同二聚体,催化胶原蛋白中羟赖氨酸的形成。最近,已从人源克隆出一种名为赖氨酰羟化酶2的同工酶[M.瓦尔塔瓦拉、H.帕波宁、A.-M.皮尔蒂拉、K.希尔图宁、H.赫兰德和R.米利拉(1997年)《生物化学杂志》272卷,6831 - 6834页]。我们在此报告第三种人赖氨酰羟化酶同工酶——赖氨酰羟化酶3的克隆情况。cDNA克隆编码一个738个氨基酸的多肽,包括一个24个残基的信号肽。加工后的人赖氨酰羟化酶3和1多肽之间的总体氨基酸序列同一性为59%,加工后的赖氨酰羟化酶3和2多肽之间的同一性为57%,而与加工后的秀丽隐杆线虫多肽的同一性仅为45%。在所有这些多肽中,催化位点的最近鉴定出的四个关键残基,即两个组氨酸、一个天冬氨酸和一个精氨酸,都是保守的。发现赖氨酰羟化酶3的mRNA在多种组织中表达,但三种同工酶mRNA的表达模式似乎存在明显差异。通过杆状病毒载体在昆虫细胞中表达的重组赖氨酰羟化酶3比在相同细胞类型中表达的赖氨酰羟化酶1更易溶解。重组赖氨酰羟化酶3和1同工酶之间未发现催化特性的差异。已知赖氨酰羟化酶1活性缺乏会导致埃勒斯-当洛综合征的VI型变体,因此,赖氨酰羟化酶3活性缺乏可能导致该综合征的某些其他变体或某些其他遗传性结缔组织疾病。